Utility of Prefrontal Space Ratio to Screen for Trisomy 21 in a Racially Diverse Population: A Pilot Study

Journal of Fetal Medicine - Tập 1 - Trang 25-27 - 2014
Barrie Suskin1, Anne-Marie Roe2, Komal Bajaj2
1Department of Obstetrics and Gynecology and Women’s Health, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, USA
2Department of Obstetrics and Gynecology, North Bronx Health Network, New York, USA

Tóm tắt

To evaluate the prefrontal space (PFS) ratio of fetuses of African descent without Down syndrome and compare it to the PFS ratio previously established in a homogeneous Caucasian population to determine whether there is a difference in the ratio in these two groups. The PFS ratio was calculated retrospectively from stored 2D images of 100 African, African-American and African-Caribbean fetuses in the second and third trimester performed at the authors’ center. Other data including the maternal age, gestational age, and ethnicity were collected. An unpaired T test was used to compare the previously published Caucasian mean, 0.97 (SD 0.29) with the mean established for the black population 1.37 (SD 0.44). The difference between these two PFS ratios was found to be significant (p < 0.0001). This pilot study suggests a significant difference in the PFS in the non-Caucasian population. In order to use the PFS as a sonographic screening tool for Down syndrome, it will be important to determine normal values in different ethnic populations.

Tài liệu tham khảo

Jones KL. Down syndrome. Smith’s recognizable patterns of human malformation. 6th ed. Philadelphia: Elsevier Saunders; 2006. p. 7. Epstein CJ. Down syndrome (trisomy 21). In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 2001. p. 1223. Driscoll D, Gross S. Prenatal screening for aneuploidy. N Engl J Med. 2009;360:2556–62. Alldred SK, Deeks JJ, Guo B, et al. Second trimester serum tests for Down’s syndrome screening. Cochrane Database Syst Rev. 2012;6:CD009925. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007;109:217. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 545: noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol. 2012;120:1532–4. Yazdi B, Sonek J, Oettling C, et al. The prefrontal space ratio in second and third trimester screening for trisomy 21. Ultrasound Obstet Gynecol. 2013;41:262–6. Sonek J, Molina F, Nicolaides KH, et al. Prefrontal space ratio: comparison between trisomy 21 and euploid fetuses in the second trimester. Ultrasound Obstet Gynecol. 2012;40(3):293–6. Farkas L, Katic M, Forrest C. International anthropometric study of facial morphology in various ethnic groups/races. J Craniofac Surg. 2005;16(4):615–46. Vioarsdottir U, O’Higgins P, Stringer C. A geometric morphometric study of regional differences in the ontogeny of the modern human facial skeleton. J Anat. 2002;201(3):211–29. Odibo AO, Stamilio DM, Nelson DB, et al. A cost-effectiveness analysis of prenatal screening strategies for Down syndrome. Obstet Gynecol. 2005;106:562–8. Harris RA, Washington AE, Nease RF Jr, Kuppermann M. Cost utility of prenatal diagnosis and the risk-based threshold. Lancet. 2004;363:276–82.